Waldenstrom’s Macroglobulinemia: Statistics

Approved by the Cancer.Net Editorial Board, 04/2016

ON THIS PAGE: You will find information about how many people are diagnosed with this type of cancer each year. You will also learn some general information on surviving the disease. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of your screen.

Waldenstrom’s macroglobulinemia is uncommon. Each year, an estimated 1,000 to 1,500 adults in the United States are diagnosed with the disease. The chance of developing Waldenstrom’s macroglobulinemia increases as people age, and the average age people are diagnosed with Waldenstrom’s macroglobulinemia is in the mid-60s.

The 5-year survival rate tells you what percent of people live at least 5 years after the cancer is found. Percent means how many out of 100. The 5-year survival rate for people with Waldenstrom’s macroglobulinemia is about 78%. However, it is important to note that survival rates vary based on a number of individual factors, including the patient’s age, how much the disease has spread at the time of diagnosis, and whether the patient has other medical problems.

It is important to remember that statistics on how many people survive this type of cancer are an estimate, and often don’t reflect the benefits of newer treatments. The estimate comes from data based on people with this cancer in the United States each year. So, your own risk may be different. Doctors cannot say for sure how long anyone will live with Waldenstrom’s macroglobulinemia. Also, experts measure the survival statistics every 5 years. This means that the estimate may not show the results of better diagnosis or treatment available for less than 5 years. Learn more about understanding statistics.

Statistics from the American Cancer Society.

The next section in this guide is Risk Factors. It explains what factors may increase the chance of developing this disease. Or, use the menu on the side of your screen to choose another section to continue reading this guide.